Erection hardness score for the evaluation of erectile dysfunction: Further psychometric assessment in patients treated by intracavernous prostaglandins injections after radical prostatectomy

Journal of Sexual Medicine

Volumn 11, Issue 8, 2014, Pages 2109-2118

  Parisot, Juliette ^a,b   Yiou, René ^a   Salomon, Laurent ^a   de la Taille, Alexandre ^a   Lingombet, Odile ^a   Audureau, Etienne ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Alprostadil; Erectile dysfunction; Prostate cancer; Validation

Indexed keywords

PROSTAGLANDIN E1; PROSTAVASIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVERGENT VALIDITY; EFFECT SIZE; ERECTILE DYSFUNCTION; ERECTION HARDNESS SCORE; FOLLOW UP; GLOBAL ASSESSMENT QUESTIONNAIRE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUMERIC PAIN SCALE; PAIN ASSESSMENT; PATIENT ASSESSMENT; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; PSYCHOMETRY; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; TIME; TREATMENT DURATION; TREATMENT RESPONSE;

ALPROSTADIL; ERECTILE DYSFUNCTION; PROSTATE CANCER; VALIDATION;

ALPROSTADIL; ERECTILE DYSFUNCTION; HARDNESS; HUMANS; INJECTIONS, INTRALESIONAL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PENILE ERECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; PSYCHOMETRICS; QUESTIONNAIRES; VASODILATOR AGENTS;

EID: 84905022663     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12584     Document Type: Article

References (43)

1. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-135.
2. Arap W. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;359:200-201, author reply 201-2.
3. Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward J, O'Connell DL, Armstrong BK. Quality of life three years after diagnosis of localised prostate cancer: Population based cohort study. BMJ 2009;339:b4817.
4. van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: A critical review. Radiother Oncol 2007;84:107-113.
5. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: A meta-analysis. J Sex Med 2009;6:2538-2546.
6. Ficarra V, Novara G, Ahlering TE, Costello A, Eastham JA, Graefen M, Guazzoni G, Menon M, Mottrie A, Patel VR, Van der Poel H, Rosen RC, Tewari AK, Wilson TG, Zattoni F, Montorsi F. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 2012;62:418-430.
7. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus S, Liebert M, Moul JW, Tangen C, Thrasher JB, Thompson I. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 2007;178:597-601.
8. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-830.
9. Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): A state-of-the-science review. Int J Impot Res 2002;14:226-244.
10. Derby CA, Araujo AB, Johannes CB, Feldman HA, McKinlay JB. Measurement of erectile dysfunction in population-based studies: The use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impot Res 2000;12:197-204.
11. Porst H, Gilbert C, Collins S, Huang X, Symonds T, Stecher V, Hvidsten K. Development and validation of the quality of erection questionnaire. J Sex Med 2007;4:372-381.
12. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397-1404.
13. Goldstein I, Mulhall JP, Bushmakin AG, Cappelleri JC, Hvidsten K, Symonds T. The erection hardness score and its relationship to successful sexual intercourse. J Sex Med 2008;5:2374-2380.
14. Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Scoring correspondence in outcomes related to erectile dysfunction treatment on a 4-point scale (SCORE-4). J Sex Med 2009;6:809-819.
15. Claes HI, Goldstein I, Althof SE, Berner MM, Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Understanding the effects of sildenafil treatment on erection maintenance and erection hardness. J Sex Med 2010;7:2184-2191.
16. Claes HI, Andrianne R, Opsomer R, Albert A, Patel S, Commers K. The HelpED study: Agreement and impact of the erection hardness score on sexual function and psychosocial outcomes in men with erectile dysfunction and their partners. J Sex Med 2012;9:2652-2663.
17. Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K. Validation of the erection hardness score. J Sex Med 2007;4:1626-1634.
18. Carson C, Giuliano F, Goldstein I, Hatzichristou D, Hellstrom W, Lue T, Montorsi F, Munarriz R, Nehra A, Porst H, Rosen R. The "effectiveness" scale-Therapeutic outcome of pharmacologic therapies for ED: An international consensus panel report. Int J Impot Res 2004;16:207-213.
19. Droupy S, Giuliano F, Costa P. [Erectile rehabilitation after radical prostatectomy]. Prog Urol 2009;19(4 suppl):S193-197.
20. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007;4:538-543.
21. Mulhall JP. The role and structure of a postradical prostatectomy penile rehabilitation program. Curr Urol Rep 2009;10:219-225.
22. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005;173:1673-1676.
23. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005;2:532-540, discussion 540-2.
24. Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med 2010;7:1687-1698.
25. Mulhall JP, Bivalacqua TJ, Becher EF. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med 2013;10:195-203.
26. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E. How urologists manage erectile dysfunction after radical prostatectomy: A national survey (REPAIR) by the French urological association. J Sex Med 2008;5:448-457.
27. Tal R, Teloken P, Mulhall JP. Erectile function rehabilitation after radical prostatectomy: Practice patterns among AUA members. J Sex Med 2011;8:2370-2376.
28. Teloken P, Mesquita G, Montorsi F, Mulhall J. Post-radical prostatectomy pharmacological penile rehabilitation: Practice patterns among the international society for sexual medicine practitioners. J Sex Med 2009;6:2032-2038.
29. Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: A systematic review of clinical data. J Sex Med 2005;2:658-667.
30. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;54:924-931.
31. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G, Miani A. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial. J Urol 1997;158:1408-1410.
32. Yiou R, Cunin P, de la Taille A, Salomon L, Binhas M, Lingombet O, Paul M, Abbou C. Sexual rehabilitation and penile pain associated with intracavernous alprostadil after radical prostatectomy. J Sex Med 2011;8:575-582.
33. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346-351.
34. Hoznek A, Salomon L, Olsson LE, Antiphon P, Saint F, Cicco A, Chopin D, Abbou CC. Laparoscopic radical prostatectomy. The Creteil experience. Eur Urol 2001;40:38-45.
35. Giuliano F, Sanchez-Ramos A, Lochner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol 2007;64:1584-1592.
36. Jensen MP, Miller L, Fisher LD. Assessment of pain during medical procedures: A comparison of three scales. Clin J Pain 1998;14:343-349.
37. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
38. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B 1995;57:289-300.
39. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44:837-845.
40. Kadioglu A, Grohmann W, Depko A, Levinson IP, Sun F, Collins S. Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: Multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase. J Sex Med 2008;5:726-734.
41. Mulhall JP, Levine LA, Junemann KP. Erection hardness: A unifying factor for defining response in the treatment of erectile dysfunction. Urology 2006;68:17-25.
42. Jannini EA, DeRogatis LR, Chung E, Brock GB. How to evaluate the efficacy of the phosphodiesterase type 5 inhibitors. J Sex Med 2012;9:26-33.
43. Glickman L, Godoy G, Lepor H. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. J Urol 2009;181:731-735.